Ainos Balance Sheet Health
Financial Health criteria checks 3/6
Ainos has a total shareholder equity of $24.4M and total debt of $5.7M, which brings its debt-to-equity ratio to 23.3%. Its total assets and total liabilities are $31.8M and $7.4M respectively.
Key information
23.3%
Debt to equity ratio
US$5.69m
Debt
Interest coverage ratio | n/a |
Cash | US$1.89m |
Equity | US$24.45m |
Total liabilities | US$7.39m |
Total assets | US$31.84m |
Recent financial health updates
We Think Ainos (NASDAQ:AIMD) Has A Fair Chunk Of Debt
Mar 10Here's Why Ainos (NASDAQ:AIMD) Can Afford Some Debt
Aug 28Here's Why Ainos (NASDAQ:AIMD) Can Afford Some Debt
May 15Recent updates
We Think Ainos (NASDAQ:AIMD) Has A Fair Chunk Of Debt
Mar 10Here's Why Ainos (NASDAQ:AIMD) Can Afford Some Debt
Aug 28Here's Why Ainos (NASDAQ:AIMD) Can Afford Some Debt
May 15Ainos rises 50% on positive data from animal study trial of Veldona to treat COVID-19
Sep 30Ainos stock rises on FDA filing for starting phase 2 trial of Veldona for COVID-19
Aug 24Amarillo Biosciences GAAP EPS of -$0.01, revenue of $636.62M
Aug 15Financial Position Analysis
Short Term Liabilities: AIMD's short term assets ($2.5M) exceed its short term liabilities ($1.3M).
Long Term Liabilities: AIMD's short term assets ($2.5M) do not cover its long term liabilities ($6.1M).
Debt to Equity History and Analysis
Debt Level: AIMD's net debt to equity ratio (15.6%) is considered satisfactory.
Reducing Debt: AIMD's debt to equity ratio has reduced from 70.3% to 23.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AIMD has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: AIMD has less than a year of cash runway if free cash flow continues to reduce at historical rates of 37.2% each year